Patents by Inventor Roberta O'CONNOR

Roberta O'CONNOR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220008443
    Abstract: Methods and compositions for preventing and/or treating diseases and conditions caused by certain apicomplexan infections are provided. The methods involve administering/providing to a subject one or more of tartrolon D and E, including isomers thereof. Exemplary apicomplexan infections that are prevented/treated by the compounds of the invention include those caused by Cryptosporidium, Babesia, Cyclospora, Isospora, Plasmodium, Sarcocystis, Besnoitia, Hammondia, Neospora, Theileria and Toxoplasma.
    Type: Application
    Filed: August 27, 2021
    Publication date: January 13, 2022
    Inventors: Roberta O'CONNOR, Eric W. SCHMIDT
  • Patent number: 11135231
    Abstract: Methods and compositions for preventing and/or treating diseases and conditions caused by certain apicomplexan infections are provided. The methods involve administering/providing to a subject one or more of tartrolon D and E, including isomers thereof. Exemplary apicomplexan infections that are prevented/treated by the compounds of the invention include those caused by Cryptosporidium, Babesia, Cyclospora, Isospora, Plasmodium, Sarcocystis, Besnoitia, Hammondia, Neospora, Theileria and Toxoplasma.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: October 5, 2021
    Assignees: Washington State University, Tufts Medical Center, Inc., University of Utah
    Inventors: Roberta O'Connor, Eric W. Schmidt
  • Publication number: 20200306276
    Abstract: Methods and compositions for preventing and/or treating diseases and conditions caused by certain apicomplexan infections are provided. The methods involve administering/providing to a subject one or more of tartrolon D and E, including isomers thereof. Exemplary apicomplexan infections that are prevented/treated by the compounds of the invention include those caused by Cryptosporidium, Babesia, Cyclospora, Isospora, Plasmodium, Sarcocystis, Besnoitia, Hammondia, Neospora, Theileria and Toxoplasma.
    Type: Application
    Filed: December 7, 2017
    Publication date: October 1, 2020
    Inventors: Roberta O'CONNOR, Eric W. SCHMIDT